Chetan Bipinchandra Shah's most recent trade in Senores Pharmaceuticals Ltd. was a Acquisition of 500 Equity Shares done at an average price of Rs. 713.5 . Disclosure was reported to the exchange on Sept. 12, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Chetan Bipinchandra Shah in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 12 Sep 2025 | 500 | 4,550 (0.01%) | 0.00% | 713.5 | 356,745 | 10 Sep 2025 10 Sep 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 29 Jul 2025 | 500 | 4,050 (0.01%) | 0.00% | 663.0 | 331,520 | 28 Jul 2025 28 Jul 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 13 Mar 2025 | 550 | 3,550 (0.01%) | 0.00% | 564.4 | 310,415 | 12 Mar 2025 12 Mar 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 3,000 (0%) | 0.00% | 561.8 | 561,830 | 25 Feb 2025 25 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 27 Feb 2025 | 1,000 | 2,000 (0%) | 0.00% | 552.4 | 552,360 | 24 Feb 2025 24 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 46 | 819 (0%) | 0.00% | 522.3 | 24,026 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 34 | 184 (0%) | 0.00% | 521.6 | 17,736 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 142 | 984 (0%) | 0.00% | 522.4 | 74,181 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 298 | 522 (0%) | 0.00% | 521.9 | 155,541 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 565 (0%) | 0.00% | 522.1 | 12,008 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 76 | 773 (0%) | 0.00% | 522.3 | 39,691 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 29 | 214 (0%) | 0.00% | 521.8 | 15,132 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 23 | 842 (0%) | 0.00% | 522.3 | 12,014 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 95 | 660 (0%) | 0.00% | 522.1 | 49,604 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 10 | 224 (0%) | 0.00% | 521.9 | 5,219 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 37 | 697 (0%) | 0.00% | 522.2 | 19,321 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 1 | 185 (0%) | 0.00% | 522 | 522 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 20 | 542 (0%) | 0.00% | 522.1 | 10,441 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |
| Senores Pharmaceuticals | Chetan Bipinchandra Shah | Director | Acquisition | 21 Feb 2025 | 16 | 1,000 (0%) | 0.00% | 522.4 | 8,359 | 19 Feb 2025 19 Feb 2025 |
Insider Trading | Equity Shares | Market Purchase |